ssaS is produced via heterologous expression:
| Host Organism | Expression Vector | Purification Method | Source |
|---|---|---|---|
| E. coli | pET28a or similar | Ni-NTA affinity columns | |
| Yeast | Undisclosed | Undisclosed |
While ssaS-specific studies are sparse, secretion systems in Salmonella are pivotal for:
Type III Secretion System (T3SS): Invades host cells via needle-like structures (e.g., PrgI) .
Type I Secretion System (T1SS): Excretes large proteins like SiiE into host cells .
ssaS may contribute to structural or regulatory aspects of these systems, though functional data remain unreported.
Recombinant ssaS could serve as:
Antigen for Immune Studies: Similar to OmpA/D, which elicits CD8+ T-cell responses in reactive arthritis .
Tool for Secretion Mechanism Studies: Analogous to SsaS homologs in other pathogens.
| Protein | System | Function | Reference |
|---|---|---|---|
| SiiE | T1SS | Giant non-fimbrial adhesin | |
| PrgI | T3SS | Needle filament component | |
| SsaS | Undetermined | Secretion apparatus role |
Current limitations include:
Functional Ambiguity: No studies explicitly link ssaS to secretion pathway regulation or effector protein translocation.
Structural Data: No crystallographic or cryo-EM data available.
Future research could explore:
Interaction Partners: Co-purification with T3SS/T1SS components.
Immunogenicity: Potential as a vaccine target or diagnostic marker.
KEGG: stm:STM1420
STRING: 99287.STM1420